Where does City Therapeutics's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across City Therapeutics's 1 recorded funding rounds.

Premier Alternatives

City Therapeutics

Drug Discovery · Cambridge, MA · Founded 2024 · Privately Held (backing)

Operator of a biotechnology company intended to develop innovative, precise, and effective treatments for a wide range of diseases. City Therapeutics is based in Cambridge, MA and was founded in 2024. It is valued at about $285 million as of Oct 2026, set by institutional fund marks. It has raised $140 million across 1 recorded round; the latest was a $135 million Series A in Oct 2024.

PMV mark · valuation

$285.5M

Oct 2026

Priced at

its Series A

Oct 2024

Total raised

$139.5M

Last round

Early Stage VC (Series A)

Oct 2024

Cap table — not yet on record

City Therapeutics's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Pro

The prices on City Therapeutics

·2 fund marks: filer, period, implied $/share

Pro · $99 a month

List $299 · founding price, locked for as long as you stay

Membership and data by Private Market View

Or create a free account

Frequently asked about City Therapeutics

Where does City Therapeutics's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across City Therapeutics's 1 recorded funding rounds.